187
Participants
Start Date
June 21, 2022
Primary Completion Date
July 15, 2024
Study Completion Date
July 31, 2026
Orca-T
an allogeneic stem cell and T-cell immunotherapy biologic
Standard-of-Care
unmanipulated donor allograft
Weill Cornell Medicine - New York-Presbyterian Hospital, New York
Memorial Sloan Kettering Cancer Center, New York
Winship Cancer Institute - Emory University, Atlanta
University of Miami Hospital and Clinics - Sylvester Comprehensive Cancer Center, Miami
Moffitt Cancer Center, Tampa
Vanderbilt University, Nashville
Sarah Cannon Research Institute, Nashville
Cleveland Clinic, Cleveland
University of Michigan Health System - Michigan Medicine, Ann Arbor
University of Chicago, Chicago
OU Health Stephenson Cancer Center, Oklahoma City
Colorado Blood Cancer Institute, Denver
University of Utah, Salt Lake City
Ronald Reagan UCLA Medical Center, Los Angeles
City of Hope, Duarte
Stanford Health Care, Stanford
UC Davis, Sacramento
Oregon Health & Sciences University - Knight Cancer Institute, Portland
Massachusetts General Hospital, Boston
Lead Sponsor
Orca Biosystems, Inc.
INDUSTRY